Aventis Files Patent Suit Over Generic Allergy Drug
In an attempt to protect the market share for its Nasacort AQ nasal spray, Aventis Pharmaceuticals Inc. filed a lawsuit Tuesday to stop Barr Laboratories Inc. from making a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article